tiprankstipranks
Trending News
More News >
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market

Maze Therapeutics, Inc. (MAZE) Similar Stocks

Compare
58 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Maze Therapeutics, Inc.
$41.71
$2.01B
-18.50
161.50%
7 Buy
0 Hold
0 Sell
Strong Buy
Cormedix
$12.02
$947.04M
5.85
40.26%
6 Buy
0 Hold
0 Sell
Strong Buy
Geron
$1.33
$849.01M
-11.06
-60.18%
3 Buy
1 Hold
0 Sell
Strong Buy
KalVista Pharmaceuticals
$15.23
$769.82M
-3.81
82.18%
9 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$49.08
$1.36B
-17.41
237.32%
10 Buy
1 Hold
0 Sell
Strong Buy
Nuvation Bio
$9.44
$3.25B
-14.75
253.56%
10 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MAZE
Maze Therapeutics, Inc.
41.71
26.71
178.07%
CRMD
Cormedix
12.02
3.60
42.76%
GERN
Geron
1.33
-2.01
-60.18%
KALV
KalVista Pharmaceuticals
15.23
6.40
72.48%
ANAB
AnaptysBio
49.08
35.11
251.32%
NUVB
Nuvation Bio
9.44
6.77
253.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts